Strange: Bullish NKTR Analysts Actually See -42.97% Downside
January 10, 2018 at 09:10 AM EST
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Nektar Therapeutics (NKTR). The average 12-month price target for NKTR averaging the work of 5 analysts reveals an average price target of $38.80/share..